AURA Aura Biosciences, Inc.

Aura Biosciences Inc is a clinical-stage oncology company developing a novel technology platform based on virus-like drug conjugates to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity.

$16.74  -1.87 (-10.05%)
As of 12/06/2021 15:59:51 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  10/29/2021
Outstanding shares:  29,210,549
Average volume:  133,674
Market cap:   $559,089,908
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   -4.27
PS ratio:   0.00
Return on equity:   13.26%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy